Petra Rubmann
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Journal: Journal of neurochemistry
Published: January 06, 2021
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs.
Journal: Molecular cancer research : MCR
Published: October 02, 2020
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.
Journal: Journal of neuro-oncology
Published: September 24, 2019
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 20, 2018
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.
Journal: Molecular cancer research : MCR
Published: October 04, 2017
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026